Information For Authors

Instructions for Authors


Aims & Scope

Transgender Health is an open access, peer reviewed journal dedicated to addressing the healthcare needs of transgender individuals throughout the lifespan and identifying gaps in knowledge as well as priority areas where policy development and research are needed to achieve healthcare equity.

The Journal aims to promote greater awareness of the health concerns of transgender populations including disparities in treatment and barriers to care, health services research including cultural competency, mental health and well-being, reproductive health, sexually transmitted infections, hormone therapy and surgery, and best practices, protocols, and guidelines to ensure optimal care.

The Journal publishes peer-reviewed original research, theoretical analysis, short reports or clinical research letters, and reviews from health, behavioral and clinical health care disciplines.  Basic science research will be considered if it has direct implications for clinical care or practice.

Open Access and Copyright

All articles published in Transgender Health are made freely and permanently accessible online upon publication without access or subscription charges, embargo periods, or user registration.

Upon submission of their manuscript, the author(s) agree to publish their article open access if it is accepted for publication. Author(s) will retain copyright of their article and a Creative Commons CC BY license will be applied. For more information, please read the full Creative Commons CC BY license.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, Liebert Open Access can accommodate non-standard copyright. Please contact

Article Publication Charges (APC)
Transgender Health is a fully open access journal. The cost of maintaining and publishing the journal are covered by Article Processing Charges (APC). Visit the Journal’s Open Access Policy page for more information about the journal’s APC. There are no color or submission charges for this journal.


Peer Review Policy

Transgender Health is a single-blind peer-reviewed journal.  All submissions to Transgender Health are subject to peer review.  Authors are encouraged, but not required, to supply the names and valid email addresses of three to four individuals who are considered qualified to review the submitted material, as well as the names of individuals whom the authors prefer not be selected as a reviewer. However, reviewer selection is ultimately at the discretion of the Editor.

Permissions and Reprints
Transgender Health publishes articles under the Creative Commons Attribution license. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without requesting prior permission from the Publisher or the author.

Mary Ann Liebert, Inc. offers a reprint service for those who require professionally produced copies of a CC-BY licensed-article. Contact: to obtain a quote. Please include the article DOI, title, number of reprint copies, and delivery destination.

Archiving and Preservation 
Mary Ann Liebert, Inc., deposits and archives all publications in Portico for long-term digital preservation. Additionally, the final published version (version of record) of all articles in the Journal will be deposited upon publication, without embargo, to PubMed Central at the U.S. National Library of Medicine (Please note that PubMed Central, not the Publisher, has sole control over when the paper is made live on PMC.) Transgender Health is fully compliant with research funders.  Your article will be free online in the Journal and will be easily searchable on Google, Google Scholar, and other search engines.

Editorial Office
Robert Garofalo, MD/MPH

Northwestern University Feinberg School of Medicine

Center for Gender, Sexuality and HIV Prevention

4711 N. Broadway

Chicago IL 60640


Submitting to the Journal

All manuscripts must be submitted online via the following URL:

All authors will need to have an account created in the system.  For technical assistance or questions, please click here.

Article Types

All articles are peer-reviewed unless otherwise noted.   Submissions should not exceed the limits for text, figures/tables, and references listed below. Original Articles present original quantitative or qualitative basic science, clinical, or psychosocial research.


Original Articles

  • Word limit:  3,000 words, excluding title, authors, abstract, keywords, figure legends, tables and table titles and/or footnotes, acknowledgments, disclosure statements, references.  Appendices count against the word limit.
  • Abstract: Standard abstract 350 word limit. See standard abstract guidelines under Manuscript Components.
  • Figures and Tables: Maximum of 10 total figures and/or tables.
  • References: Maximum of 100 references.

Review Articles

  • Word limit:  5,000 words, excluding title, authors, abstract, keywords, figure legends, tables and table titles and/or footnotes, acknowledgments, disclosure statements, references.  Appendices count against the word limit.
  • Abstract:  Standard abstract 250 word limit, but structured headings not required.
  • Details on the study selection and inclusion process and on the participants in each selected study should be included.
  • Figures and Tables: Maximum of 10 total figures and/or tables.
  • References: Maximum of 150 references.

Short Reports
(Clinical research letters, particularly promising preliminary findings, or other research findings or commentaries that are not suitable for a full Original Article)

  • Word limit:  1,500 words, excluding title, authors, abstract, keywords, figure legends, tables and table titles and/or footnotes, acknowledgments, disclosure statements, references.  Appendices count against the word limit.
  • Abstract: Include a brief abstract of 100 words or less; structured headings are not required.
  • Text: 2,000 word limit. Include a concise literature review and a brief overview of the study, sufficient details on the study's methods and analysis, and a brief summarizing conclusion.
  • Figures and Tables: Maximum of 3 total figures and/or tables.
  • References: Maximum of 25 references.

Perspectives present opinions and insights on a current topic, describe novel hypotheses, or consider controversial issues, including legal, policy, and ethical issues. These articles may provide critical commentary on recent advances and future directions and discuss implications for clinical practice or public health. The perspective and points in the article should be supported by relevant literature.

Perspectives should include the following components:

  • Word limit:  1,500 words; excluding title, authors, abstract, keywords, figure legends, tables and table titles and/or footnotes, acknowledgments, disclosure statements, references.  Appendices count against the word limit.
  • Abstract: Structured headings are not required (100 word limit)
  • Text: Introduction and a Conclusion are mandatory
  • References: Maximum of 25 references
  • Figure Legends
  • Tables and Figures: A maximum of 3 total figures and/or tables (combined) is permitted.

Letters to the Editor:  Comments on recently published Transgender Health articles.

  • Special Notes: Include a short title related to but distinct from the published article being addressed. Provide the standard title page, but no running head or Keywords. The Editors may choose to invite the authors to submit a response to the Letter. Not peer reviewed.
  • Text: 500 word limit.
  • Figures and Tables: Maximum of 1 total figure and/or table.
  • References: No more than 5 references, one of which must be the Transgender Health article being discussed.

Case Reports


In general, Case Reports and Case-Series Reports are not considered journal priorities and will only be considered if they make significant and/or major contributions to the field.


Online Manuscript Submission

Manuscripts must be uploaded to in a word processing format, preferably in Microsoft Word. Do not submit the manuscript or any of its components in PDF format. All authors on a submitted manuscript must have a Manuscript Central account.  If you do not already have an account in Manuscript Central for Transgender Health, you will need to create one.  Once you create your account, you may log in to the system to begin your submission.


Keywords and Abstract
Provide a minimum of four keywords when uploading your manuscript.  These keywords will facilitate the review process and will be published as part of the paper. 

Suggested Reviewers

Authors are encouraged to suggest the names and institutional email addresses of appropriate reviewers during Manuscript Central submission, though final selection of reviewers is at the discretion of the Editors.

Cover Letter

Please include a cover letter from the corresponding author. The cover letter should include the following:

  • A statement indicating that the paper has not been previously published in any form
  • Abstract word count
  • Main text word count
  • Number of tables
  • Number of figures
  • Number of appendices (if applicable)
  • Authors are encouraged to detail the significance and uniqueness of the work in a single paragraph

Manuscript Components

General Formatting and Style

Use of English Language: All submissions must be in English. Transgender Health uses American-style English.  Appropriate use of the English language is a requirement for review and publication in the Journal.  For authors whose native language is not English, and for those who wish to invest in assistance to improve the compositional quality of their manuscripts, we suggest using a service that can aid in the translation and editing of material into correct and proper academic/business English.  The Publisher offers a paid editing service.  Fees are determined on an individual basis and reflect the length and complexity of the document. Fees are solely the responsibility of the author(s).  Employing this service, or any other editing service, does not imply or guarantee acceptance of any submission. It serves simply to improve the manuscript for proper English grammar and usage, rendering it more presentable for review purposes and potential publication. For more information regarding the Publisher’s editing services, contact

  • Plagiarism: All submitted manuscripts will be processed through plagiarism detection software. Plagiarized manuscripts will be rejected immediately.
  • Font: Times New Roman or Arial in 12-point type
  • Abbreviations: Expand all abbreviations at first mention in the text
  • Page size: Letter size (8.5 x 11 inches)
  • Margins: 1 inch
  • Line and word spacing: Double-space all manuscript pages, including figure legends.

Title Page

The title (first) page of all manuscripts must contain the following information:

1.   Exact title (No proprietary names, trade names, or abbreviations should be within the article title)

2.   All participating authors should be listed on the manuscript at the time of submission.  Changes in authorship will not be permitted after acceptance of a paper.

3.   For each author:

  • Full name, including middle initial if applicable
  • Primary academic degrees (such as MD, DO, PhD, MPH, etc. No undergraduate or honorary degrees, fellowship or society memberships, etc.)
  • Institutional affiliation(s)
  • City, state, and country for each affiliation
  • Email address
  • Note: 
  1. Group authors (i.e., “…on behalf of the XYZ Study”) are permissible
  2. Co-first authors are also permitted. On the title page, please put an asterisk after each co-first author and note them as such

 4.  Corresponding author:

  • Full name, including middle initial if applicable
  • Primary academic degrees (such as MD, DO, PhD, MPH, etc. No undergraduate or honorary degrees, fellowship or society memberships, etc.)
  • Institutional affiliation(s)
  • City, state, and country for each affiliation
  • Full mailing address
  • Phone number
  • Fax number
  • Email address

5.    Running head:

  • 50 characters or fewer (including spaces; abbreviations acceptable)

6.    Keywords:

  • Provide 4-6 keywords to be included in the article

Abstract (must be included within the text of the manuscript)

A structured abstract using the following guidelines should accompany every manuscript unless otherwise noted above under Article Types. The abstract should appear on a separate page after the title page. The abstract should be no more than 250 words, formatted with the following headings: 

              - Purpose
              - Methods
              - Results
              - Conclusion

  • Do not use proprietary or trade names
  • References are not permitted in the abstract



After the Conclusion of the main body of the manuscript, include a separate section acknowledging any contributors who did not meet the requirements for authorship and any science writers or corporate employees who participated in the development of the manuscript. Also include acknowledgments of research support for the study.


Following the Acknowledgments section (or Disclaimer if one was included), include a section entitled ‘‘Author Disclosure Statement.’’ Here authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals for further guidance. If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’

Provide all appropriate details if any part of the manuscript was previously presented.


Study Design and Ethics

Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) should be required for all studies involving people, medical records, and human tissues. For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.

Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements.

Definitions of Scientific Misconduct

Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.

  •  Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.

  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.

  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.

  • Material failure to comply with legislative and regulatory requirements affecting research:
    Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.

  • Conflict of Interest:  Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.

  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.

  • Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.

  • Simultaneous Submission:  Submitting a paper to more than one publication at the same time constitutes misconduct.

Responding to Allegations of Possible Misconduct

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation.  As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper.  In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record.  If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential.

When articles include reports of studies on human subjects, state in the Methods section that an appropriate institutional review board or ethics committee approved the study. Authors who do not have formal ethics review committees should follow the principles of the Declaration of Helsinki. In the Methods section, state that informed consent was obtained from subjects (specify written or verbal).

The principal author must state that if animals were used experimentally, permission was obtained from the appropriate committee(s), and that the animals were treated humanely and the standards conformed to those of current ethical animal research practices.

In addition, text and photographs should not reveal any identifying information unless it is essential for scientific purposes (in which case, consent should be obtained). Masking the subjects’ eyes in photographs is often insufficient to protect their identity.


Authors are responsible for the accuracy and completeness of their references. Number references in the order they are cited in the text; do not alphabetize. In-text citations should be in numerical order, superscripted, not contained within parentheses or brackets, and placed after punctuation.

  • Check the Article Types section for reference number limits for some article types
  • Begin the Reference section on a separate page after the Author Disclosure Statement section
  • Double-space all lines and single-space between words
  • Articles accepted and in press are included in the Reference section
  • Personal communications, unpublished data, or manuscripts “in preparation” or “submitted for publication” should not be included in the Reference section. If necessary, these should be included at the appropriate place in the body of the text. Personal communications should include the contact’s first initial and last name, and the month and year of the communication
  • List all authors and/or editors up to 4; for 5 or more, list the first 3 followed by “et al.”
  • For books, volume and edition numbers should be included when appropriate
  • Abbreviate journal names in accordance with PubMed / MEDLINE
  • No PMIDs or PCMIDs
  • References that are abstracts should be indicated as such, with the abstract number included, if applicable
  • Citation formats are based on NLM style, please see below for specific Transgender Health format examples 

Reference Samples

Journal article
Zelle A, Arms T. Psychosocial effects of health disparities of lesbian, gay, bisexual, and transgender older adults. J Psychosoc Nurs Ment Health Serv. 2015;53:25-30.

Teich NM.  Transgender 101:  A Simple Guide to a Complex Issue.  New York: Columbia Press University, 2012.

Chapter in an edited book

Monstrey SJ, Buncamper M, Bouman M-B, Hoebeke P.  Surgical interventions for gender dysphoria.  In:  Gender Dysphoria and Disorders of Sex Development: Progress in Care and Knowledge (Focus on Sexuality Research).  (Kreukels BPC, Steensma TD, de Vries ALC; eds).  New York:  Springer, 2014, pp. 299–318.


Task Force Report    
American Psychological Association Task Force on Gender Identity and Gender Variance. Report of the Task Force on Gender Identity and Gender Variance.  2008. Washington, DC, American Psychological Association. 

Publication by an association 
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision. DSM-IV-TR ed. Washington, DC, 2000.

Within the text, cite tables in the order in which they appear using Arabic numerals. Tables in accepted articles will be typeset and placed near the first mention of the table in the text; do not include separate lines indicating table placement.

Table guidelines

  • Check the Article Types section for limits on the number of tables and/or figures for some article types
  • Prepare all tables in one separate Word file.  Do not include them in the main text file, and do not embed them in text where they are cited.
  • Provide a brief but descriptive title for each table. Avoid abbreviations in the table title when possible
  • Table footnote(s) should include any essential notes and must include definitions of all abbreviations and acronyms used in the table


Within the text, cite figures in the order in which they appear using Arabic numerals. Figures in accepted articles will be typeset and placed near the first mention of the figure in the text; do not include separate lines indicating figure placement.

Figure guidelines: 

  • Check the Article Types section for limits on the number of tables and/or figures for some article types
  • Figures include graphs, charts, diagrams, illustrations, and photographic images
  • File types and guidelines:

             - All figures must be submitted as separate picture files.  Do not embed figures in the main word processing document.

             - Do not submit figures as PDFs, PowerPoint, or Excel files

             - To ensure proper print quality, please submit only TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process

              - Line illustrations should be submitted at 900 DPI.  Halftones and color should be submitted at a minimum of 300 DPI

-      Name figure files using only alphanumeric characters.  Do not use symbols or other special characters.  (Ex:  SmithFig1)


  •  Color figures:

             - Color art must be saved as CYMK, not RGB. (Note: If RGB files are submitted, the files will be converted to CYMK and some color  variation will occur)

  • Figure legends:

              - After the Reference section of the main word processing document (or any Tables included in the word processing document), include a separate page with the following information for each figure:
             - Provide a brief but descriptive title for each figure. Avoid abbreviations in the figure title when possible

             - Define all relevant information in figures, including figure part labels, footnotes, abbreviations, acronyms, arrows,
               and levels of  magnification in insets

Online-Only Materials

Appendices and other supplementary materials should be included only when they are pertinent to the submitted manuscript but beyond the word or table/figure limits.

Appendix and supplementary material guidelines:

  • Published only with the online version of an accepted article
  • The print version of the article will include a URL directing readers to the online-only materials
  • Should be important to understanding or interpretation of the manuscript and limited in length
  • Should be original and not previously published
  • Acceptance of online-only materials is separate from acceptance of the manuscript and at the Editors’ discretion
  • Authors are encouraged to contact the Editor prior to submission of online-only materials



Post-Submission Information

Submission-Related Emails and Online Status

The Manuscript Central system sends emails only to the corresponding author. Submitted manuscripts will show in the Manuscript Central Author Center of only the corresponding author.

Manuscript Decisions

Manuscripts may receive decisions of Reject, Major Revision, Minor Revision, Accept with Edits, or Accept. A manuscript decision of Major Revision or Minor Revision does not guarantee the manuscript will ultimately be accepted. Article type word limits apply to revisions as well as initial submissions. A manuscript with a decision of Accept with Edits will not receive a formal Accept decision until all requested edits are satisfactorily completed.


It is the submitting author’s responsibility to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon submission. Once a paper is accepted for publication, changes in authorship while the paper is in production – including page proofs – are NOT permitted. Changes in authorship after publication are prohibited.


Authors are responsible for procuring permissions to reproduce illustrations or tables taken from other publications and must be acknowledged by a complete credit line in the figure legend. The original publisher’s letter of permission should be available for submission to Transgender Health if requested by the Editors or the Publisher. A full citation should also be included in the Reference section.

Page Proofs

An email containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read carefully and returned within 3 business days to the Publisher with the author’s/authors’ approval or corrections.


Transgender Health is published by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; Fax: (914) 740-2101; Email:   Website:

Transgender Health is a journal of broad interest that has been launched to overcome unnecessary barriers to the immediate availability and use of research.

Benefits of publishing in Transgender Health:

  • High visibility, immediate and unrestricted online access to published articles
  • Rigorous peer review
  • Easy compliance with open access mandates
  • Authors retain copyright 
  • Highly indexed – citation tracking and inclusion in bibliographic databases
  • Targeted email marketing

The article publication charge for Transgender Health is $1,000.00 USD for accepted publications.

Copyright and Licensing
Transgender Health publishes articles under the liberal CC-BY license. This means that articles can be freely redistributed and reused by the author and others as long as the article is properly cited. Published articles in Transgender Health can be deposited immediately into an online repository or social network without an embargo. Transgender Health articles can be emailed to colleagues, printed, archived in a collection, included in course-packs, and distributed without restrictions. Please read the full Creative Commons license for further information.



The final published version (version of record) of all articles published in Transgender Health are immediately deposited into PubMed Central (PMC) on behalf of the authors. Authors need not take any action. This service is provided free of charge.

*Please note that PubMed Central, not the Publisher, has sole control over when the paper is made live on PMC.

Publishing in Open Access Journals

There are no archiving restrictions for open access articles published under creative commons licenses. Author manuscripts and the final published version of any article published in Transgender Health can be archived in a repository, preprint server, or shared on a research network without an embargo.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.